TWST
Twist Bioscience Corporation
Stock
$188.67+0.62 (+0.33%)Close Oct 2, 2026
Balance sheet
| Line | Q3 FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $167M | $232M | $276M | $336M | $505M | $478M | $290M | $138M | $81M | $31M | — |
| Inventory | $35M | $28M | $24M | $32M | $39M | $32M | $12M | $7.3M | $6.0M | — | — |
| Current assets | $321M | $333M | $347M | $424M | $596M | $546M | $335M | $160M | $96M | — | — |
| Goodwill | $82M | $82M | $86M | $86M | $86M | $22M | $1.1M | $1.1M | $1.1M | — | — |
| Intangible assets | $13M | $13M | $14M | $54M | $60M | $18M | $307K | $508K | $712K | — | — |
| Total assets | $672M | $642M | $614M | $776M | $961M | $702M | $399M | $187M | $116M | — | — |
| Current liabilities | $120M | $91M | $71M | $73M | $91M | $63M | $36M | $30M | $19M | — | — |
| Long-term debt | — | — | — | — | — | — | $1.4M | $4.4M | $7.2M | — | — |
| Total liabilities | $227M | $169M | $142M | $153M | $172M | $121M | $63M | $35M | $27M | — | — |
| Shareholders' equity | $446M | $473M | $473M | $623M | $789M | $581M | $336M | $152M | −$201M | −$133M | −$77M |
| Shares outstanding | 62.7M | 61.1M | 59.4M | 57.7M | 56.6M | 49.6M | 45.2M | 33.1M | — | — | — |
| Current ratio | 2.67 | 3.64 | 4.88 | 5.79 | 6.58 | 8.67 | 9.29 | 5.28 | 5.16 | — | — |